A new animal study, presented at EuroPCR (17–20 May, Paris), indicates that a novel, fluoropolymer-coated, self-expanding, paclitaxel-eluting peripheral stent (Eluvia, Boston Scientific) is associated with significantly less neointima at 90 days than is a no polymer, paclitaxel-eluting peripheral stent (Zilver PTX, Cook Medical). Eluvia, which is CE marked but an investigational device in the USA, was also associated with more uniform neointimal coverage.
Vasorum has received approval of its premarket approval application from the US Food and Drug Administration (FDA). Celt ACD, which has received CE mark and is sold in Europe, is indicated for arterial puncture closure in both diagnostic and anticoagulated percutaneous interventional cardiology and radiology patients.
Positive twelve-month results from Intact Vascular’s Tack optimised balloon angioplasty—below-the-knee (TOBA-BTK) clinical study have been presented at the SCAI 2016 conference (4–7 May, Orlando, USA) by Christian Wissgott, assistant director at Westküstenklinikum Heide in Heide, Germany.
The background of the study is that historically, more advanced disease of the lower extremities has been most commonly treated with open surgical bypass. Although successful, this surgical approach is not without significant potential morbidity....
Twelve-month results from the MAJESTIC trial evaluating the performance of the Eluvia drug-eluting stent demonstrated a primary patency rate of 100% amongst diabetic patients and no target lesion revascularisations in this subgroup.
BOSTON -- Type 1 diabetes patients younger than 40 may be candidates for statin use, as guidelines recommend after age 40, researchers suggested.
Studies have shown an association between strict control of blood sugar and increased mortality. They have also suggested that a consequence of this control is low blood sugar (hypoglycemia), which may have adverse effects on the heart. In a new study, researchers examined the effects of hypoglycemia on cardiovascular autonomic control. They found that in their experimental model of hypoglycemia, there was a clear change in the body's responses to cardiovascular stress.
topic of vitamin D supplementation is a vast minefield of purported benefits - and lack thereof. Now, a new study suggests taking vitamin D supplements improves exercise performance and lowers the risk of heart disease.
Among three patients who had declined the glucocorticoids, clinicians often turn to first, IVIG monotherapy restored partial or full muscle strength and cut biomarkers of muscle damage as well, reported Andrew L. Mammen, MD, PhD, of the NIH in Bethesda, Md., and Eleni Tiniakou, MD, of Johns Hopkins University School of Medicine in Baltimore.
Midday naps are associated with reduced blood pressure levels and prescription of fewer antihypertensive medications, according to research presented at ESC Congress today by Dr Manolis Kallistratos, a cardiologist at Asklepieion Voula General Hospital in Athens, Greece.
During major surgeries, patients often need transfusions of red blood cells to replace the blood they have lost. However, the question of whether stored blood is safe for heart surgery patients has had mixed answers. Now, a new study suggests blood stored between 14-42 days is, in fact, safe to use.
new study suggests severity of the skin condition psoriasis is associated with increased inflammation of the blood vessels, or vasculitis.
Significant annual cost savings found with UrgoStart in UK and Germany
Thrombolex announces 510(k) clearance of Bashir catheter systems for thromboembolic disorders
SAVE-US pivotal trial completes enrollment and has positive clinical results
Endologix announces reinstatement of CE mark for its Nellix endovascular aneurysm sealing system
Who should have a Cardiac CT?
Phone: (028) 3981 2678
Mobile: 0903 839 878 - 0909 384 389